OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 8 citing articles:

Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time
Grace Kenny, Sophie O’Reilly, N. Kelly, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14

Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project
S. K. Malik, Zoi Dorothea Pana, Christos D. Argyropoulos, et al.
JMIR Medical Informatics (2025) Vol. 13, pp. e65590-e65590
Open Access

Sharing sensitive data in life sciences: an overview of centralized and federated approaches
Maria A. Rujano, Jan‐Willem Boiten, Christian Ohmann, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 3

Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)
Julia Neuhann, Jannik Stemler, Antonio J. Carcas, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7166-7175
Open Access | Times Cited: 7

Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper
Ullrich Bethe, Zoi Dorothea Pana, Christian Drosten, et al.
Infection (2024)
Open Access | Times Cited: 1

The Challenge of Misleading Information: Does the Interaction between Zinc and Vitamin D Influence the Immune Response against SARS-CoV-2 in the Elderly Population?
Deise Maria Rego Rodrigues Silva, Pedro Henrique Macedo Moura, Gopalsamy Rajiv Gandhi, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1277-1277
Open Access

Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107161-107161
Closed Access

Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project (Preprint)
S. K. Malik, Zoi Dorothea Pana, Christos D. Argyropoulos, et al.
(2024)
Closed Access

Page 1

Scroll to top